This is a synthetic peptide designed for use in combination with anti-U2AF1L4 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeat freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
Splicing factor U2AF 26 kDa subunit (U2AF1L4)
Synonyme
U2 small nuclear RNA auxiliary factor 1-like protein 3 Peptide, U2AF1-RS3 Peptide, U2AF1-like 4 Peptide, U2AF1-like protein 3 Peptide, U2AF1L3 Peptide, U2AF1L3V1 Peptide, U2AF1RS3 Peptide, U2af26 Peptide, AA407033 Peptide, AF419339 Peptide, AI451269 Peptide, AW553050 Peptide, TMEM149 Peptide, U2 small nuclear RNA auxiliary factor 1 like 4 Peptide, U2 small nuclear RNA auxiliary factor 1-like 4 Peptide, U2AF1L4 Peptide, U2af1l4 Peptide
Hintergrund
U2AF1L4 is a RNA-binding protein that function as a pre-mRNA splicing factor. It plays a critical role in both constitutive and enhancer-dependent splicing by mediating protein-protein interactions and protein-RNA interactions required for accurate 3'-splice site selection. It acts by enhancing the binding of U2AF2 to weak pyrimidine tracts and also participates in the regulation of alternative pre-mRNA splicing. It activates exon 5 skipping of PTPRC during T-cell activation, an event reversed by GFI1. U2AF1L4 binds to RNA at the AG dinucleotide at the 3'-splice site.